OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
00275356

Shanxi Yongdong Chemistry Industry Co Ltd

Commodity ChemicalsVerified

Shanxi Yongdong Chemistry Industry Co Ltd maintains a relatively strong liquidity position, with a current ratio of 5.1, indicating that it holds significantly more current assets than current liabilities. However, the company has a negative net cash position after subtracting total debt, which raises concerns about its short-term liquidity. The debt-to-equity ratio of 0.31 suggests a conservative capital structure, with total liabilities accounting for a small portion of total equity. Profitability metrics show that the company is generating modest returns. Return on equity (ROE) is 4.77%, and return on assets (ROA) is 3.41%, both below the typical thresholds for high-performing chemical firms. These figures suggest that the company is not efficiently utilizing its equity or assets to generate returns. Gross profit of 223.4 million CNY and operating income of 130.9 million CNY indicate that the company is maintaining a narrow margin, which is common in the commodity chemicals industry. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification increases exposure to sector-specific risks, such as commodity price volatility and regulatory changes. Geographically, the company is based in China, and its operations are likely concentrated in the domestic market, though no specific geographic breakdown is available. Looking ahead, the company's growth trajectory is uncertain. No specific revenue growth projections are provided, and historical revenue data does not show a clear upward trend. The company reported capital expenditures of -57.6 million CNY, which may indicate a reduction in investment or a reclassification of expenses. This could signal a strategic shift or a response to market conditions. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued additional shares recently. The risk assessment also flags the company's net cash position as a concern, which could limit its ability to fund operations or invest in growth opportunities. No recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance. The company's financial performance and risk profile suggest that it is operating in a stable but low-margin environment. The conservative capital structure and strong current ratio provide some buffer against short-term liquidity challenges, but the low ROE and ROA indicate that the company is not outperforming its peers in terms of profitability. Investors should monitor the company's ability to maintain or improve its margins in the face of industry headwinds.

30-day price · 002753(missing data)
No daily-bar history available from current data sources. Alternate source pending.
Profile
CompanyShanxi Yongdong Chemistry Industry Co Ltd
Ticker002753.SZ
SectorBasic Materials
BusinessChemicals
Industry groupChemicals
IndustryCommodity Chemicals
AI analysis

Business. Shanxi Yongdong Chemistry Industry Co Ltd is a chemical manufacturing company that produces and sells commodity chemicals, primarily generating revenue through the sale of chemical products to industrial and commercial customers.

Classification. The company is classified under the Basic Materials economic sector, Chemicals business sector, and Commodity Chemicals industry, with a classification confidence of 0.92 based on verified market data.

Shanxi Yongdong Chemistry Industry Co Ltd maintains a relatively strong liquidity position, with a current ratio of 5.1, indicating that it holds significantly more current assets than current liabilities. However, the company has a negative net cash position after subtracting total debt, which raises concerns about its short-term liquidity. The debt-to-equity ratio of 0.31 suggests a conservative capital structure, with total liabilities accounting for a small portion of total equity. Profitability metrics show that the company is generating modest returns. Return on equity (ROE) is 4.77%, and return on assets (ROA) is 3.41%, both below the typical thresholds for high-performing chemical firms. These figures suggest that the company is not efficiently utilizing its equity or assets to generate returns. Gross profit of 223.4 million CNY and operating income of 130.9 million CNY indicate that the company is maintaining a narrow margin, which is common in the commodity chemicals industry. The company's revenue is concentrated in a single business segment, as no segmental breakdown is provided in the available data. This lack of diversification increases exposure to sector-specific risks, such as commodity price volatility and regulatory changes. Geographically, the company is based in China, and its operations are likely concentrated in the domestic market, though no specific geographic breakdown is available. Looking ahead, the company's growth trajectory is uncertain. No specific revenue growth projections are provided, and historical revenue data does not show a clear upward trend. The company reported capital expenditures of -57.6 million CNY, which may indicate a reduction in investment or a reclassification of expenses. This could signal a strategic shift or a response to market conditions. Risk factors include a medium liquidity risk due to the negative net cash position and a low dilution risk, as the company has not issued additional shares recently. The risk assessment also flags the company's net cash position as a concern, which could limit its ability to fund operations or invest in growth opportunities. No recent filings or transcripts are available to provide additional context on the company's strategic direction or operational performance. The company's financial performance and risk profile suggest that it is operating in a stable but low-margin environment. The conservative capital structure and strong current ratio provide some buffer against short-term liquidity challenges, but the low ROE and ROA indicate that the company is not outperforming its peers in terms of profitability. Investors should monitor the company's ability to maintain or improve its margins in the face of industry headwinds.
Key takeaways
  • The company has a strong current ratio of 5.1, indicating good short-term liquidity.
  • Return on equity and return on assets are below industry norms, suggesting suboptimal capital efficiency.
  • The company's revenue is likely concentrated in a single business segment, increasing exposure to sector-specific risks.
  • Capital expenditures are negative, which may indicate a strategic shift or reduced investment in growth.
  • The company has a low dilution risk, but its net cash position is negative after subtracting total debt.
  • No recent filings or transcripts are available to provide additional insight into the company's strategic direction.
  • --
  • ## RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyCNY
Revenue$4.23B
Gross profit$223.4M
Operating income$130.9M
Net income$111.4M
R&D
SG&A
D&A
SBC
Operating cash flow$66.0M
CapEx-$57.6M
Free cash flow$72.6M
Total assets$3.26B
Total liabilities$928.3M
Total equity$2.34B
Cash & equivalents
Long-term debt$733.2M
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$2.34B
Net cash-$733.2M
Current ratio5.1
Debt/Equity0.3
ROA3.4%
ROE4.8%
Cash conversion59.0%
CapEx/Revenue-1.4%
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Chemicals · cohort 11 companies
Metric002753Activity
Op margin3.1%0.4% medp25 -8.0% · p75 16.0%above median
Net margin2.6%2.3% medp25 -11.6% · p75 11.8%above median
Gross margin5.3%20.8% medp25 14.9% · p75 24.0%bottom quartile
R&D / revenue1.1% medp25 0.5% · p75 1.3%
CapEx / revenue-1.4%6.2% medp25 5.4% · p75 10.2%bottom quartile
Debt / equity31.0%59.0% medp25 54.9% · p75 72.9%bottom quartile
Source: analysis-pipeline (hybrid)Generated: 2026-05-20 03:39 UTCJob: 286abf0b